Noninvasive estimation of hepatic steatosis in living liver donors: Usefulness of visceral fat area measurement

Transplantation

Volumn 88, Issue 4, 2009, Pages 575-581

  Yamashiki, Noriyo ^a   Sugawara, Yasuhiko ^a   Tamura, Sumihito ^a   Kaneko, Junichi ^a   Matsui, Yuichi ^a   Togashi, Junichi ^a   Ohki, Takamasa ^a   Yoshida, Haruhiko ^a   Omata, Masao ^a   Makuuchi, Masatoshi ^a,b   Kokudo, Norihiro ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b JAPANESE RED CROSS MEDICAL CENTER   (Japan)

Author keywords

Dietary intervention; Donor selection; Hepatic steatosis; Outcome; Visceral fat area

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE;

ADULT; ARTICLE; AUTOIMMUNE HEPATITIS; BILE DUCT ATRESIA; BODY FAT DISTRIBUTION; BODY MASS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ECHOGRAPHY; FATTY LIVER; FEMALE; HUMAN; HUMAN TISSUE; INTRAABDOMINAL FAT; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FAILURE; LIVER TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL ASSESSMENT; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; SUBCUTANEOUS FAT; SURVIVAL RATE;

ADULT; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; BIOPSY, NEEDLE; FATTY LIVER; FEMALE; HUMANS; INTRA-ABDOMINAL FAT; LIVER TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; ROC CURVE; SURVIVAL RATE; TISSUE AND ORGAN PROCUREMENT; YOUNG ADULT;

EID: 70349156449     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181b11c19     Document Type: Article

References (36)

1. Chen CL, Fan ST, Lee SG, et al. Living-donor liver transplantation: 12 years of experience in Asia. Transplantation 2003; 75: S6.
2. Sugawara Y, Makuuchi M. Advances in adult living donor liver transplantation: A review based on reports from the 10th anniversary of the adult-to-adult living donor liver transplantation meeting in Tokyo. Liver Transpl 2004; 10: 715.
3. Freeman RB, Steffick DE, Guidinger MK, et al. Liver and intestine transplantation in the United States, 1997-2006. Am J Transplant 2008; 8: 958.
4. Settmacher U, Theruvath T, Pascher A, et al. Living-donor liver transplantation-European experiences. Nephrol Dial Transplant 2004;19(suppl 4): iv16.
5. Yamashiki N, Sugawara Y, Tamura S, et al. Selection of liver-transplant candidates for adult-to-adult living donor liver transplantation as the only surgical option for end-stage liver disease. Liver Transpl 2006; 12: 1077.
6. Imber CJ, St.Peter SD, Handa A, et al. Hepatic steatosis and its relationship to transplantation. Liver Transpl 2002; 8: 415.
7. Todo S, Demetris AJ, Makowka L, et al. Primary nonfunction of hepatic allografts with preexisting fatty infiltration. Transplantation 1989; 47: 903.
8. Verran D, Kusyk T, Painter D, et al. Clinical experience gained from the use of 120 steatotic donor livers for orthotopic liver transplantation. Liver Transpl. 2003;9:500.
9. Brown RS, Russo MW, Lai M, et al. A survey of liver transplantation from living adult donors in the United States. N Engl J Med 2003; 348: 818.
10. Trotter JF, Campsen J, Bak T, et al. Outcomes of donor evaluations for adult-to-adult right hepatic lobe living donor liver transplantation. Am J Transplant 2006; 6: 1882.
11. Valentin-Gamezo C, Malago M, Karliova M, et al. Experience after the evaluation of 700 potential donors for living donor liver transplantation in a single center. Liver Transpl 2004; 10: 1087.
12. Hwang S, Lee SG, Lee YJ, et al. Lessons learned from 1000 living donor liver transplantations in a single center: How to make living donation safe. Liver Transpl 2006; 12: 920.
13. Reddy KR, Mallat DB, Jeffers LJ. Evaluation of the liver: Liver biopsy and laparoscopy. In: Schiff ER, Sorrell MR, Maddrey WC, eds. Schiff's diseases of the liver. Philadelphia, Lippincott Williams & Wilkins 2003, p 257.
14. Iwasaki M, Takada Y, Hayashi M, et al. Noninvasive evaluation of graft steatosis in living donor liver transplantation. Transplantation 2004; 78: 1501.
15. Park SH, Kim PN, Kim KW, et al. Macrovesicular hepatic steatosis in living liver donors: Use of CT for quantitative and qualitative assessment. Radiology 2006; 239: 105.
16. Lee JY, Kim KM, Lee SG, et al. Prevalence and risk factors of nonalcoholic fatty liver disease in potential living liver donors in Korea: A review of 589 consecutive liver biopsies in a single center. J Hepatol 2007; 47: 239.
17. World Health Organization, Global database on body mass index. Available at http://www.who.int/bmi/index.jsp?introPage-intro-3. html. Accessed October 24, 2008.
18. Zwiebel WJ. Sonographic diagnosis of diffuse liver disease. Semin Ultrasound CT MR 1995; 16: 8.
19. Kokudo N, Sugawara Y, Imamura H, et al. Tailoring the type of donor hepatectomy for adult living donor liver transplantation. Am J Transplant 2005; 5: 1694.
20. Kvist H, Chowdhury B, Sjostrom L, et al. Adipose tissue volume determination in males by computed tomography and 400K. Int J Obes 1988; 12: 249.
21. Farrell GC, Larter CZ. Nonalcohlic fatty liver disease: From steatosis to cirrhosis. Hepatology 2006; 43: S99.
22. Rinella ME, Alonso E, Rao S, et al. Body mass index as a predictor of hepatic steatosis in living liver donors. Liver Trnanspl 2001; 7: 409.
23. Ryan CK, Johnson LA, Germin BI, et al. One hundred consecutive hepatic biopsies in the workup of living donors for right lobe liver transplantation. Liver Transpl 2002; 8: 1114.
24. Tran TT, Changsri C, Shackleton CR, et al. Living donor liver transplantation: Histological abnormalities found on liver biopsies of apparently healthy potential donors. J Gastroenterol Hepatol 2006; 21: 381.
25. Marchesini G, Bugianesi E, Forlani G, et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 2003; 37: 917.
26. Sobhonslidsuk A, Jongjirasiri S, Thakkinstian A, et al. Visceral fat and insulin resistance as predictors of non-alcoholic steatohepatitis. World J Gastroenterol 2007; 13: 3614.
27. Hamaguchi M, Kojima T, Itoh Y, et al. The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation. Am J Gastroenterol 2007; 102: 2708.
28. Sorbi D, Boynton J, Lindor KD. The ratio of aspartate aminotransferase to alanine aminotoransferase: Potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease. Am J Gastroenterol 1999; 94: 1018.
29. Angulo P, Keach JC, Batts KP, et al. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 1999; 30: 1356.
30. Prati D, Taloli E, Zanella A, et al. Updated definitions of healthy range for serum alanine aminotransferase levels. Ann Intern Med 2002; 137: 1.
31. Kunde SS, Lazenby AJ, Clements RH, et al. Spectrum of NAFLD and diagnostic implications of the proposed new normal range for serum ALT in obese women. Hepatology 2005; 42: 650.
32. Ueno T, Sugawara H, Sujaku K, et al. Therapeutic effects of restricted diet and exercise in obese patients with fatty liver. J Hepatol 1997; 27: 103.
33. Hickman IJ, Jonsson JR, Prins JB, et al. Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin, and quality of life. Gut 2004; 53: 413.
34. Huang MA, Greenson JK, Chao C, et al. One-year intense nutritional counseling results in histological improvement in patients with nonalcoholic steatohepatitis: A pilot study. Am J Gastroenterol 2005; 100: 1072.
35. Nakamuta M, Morizono S, Soejima Y, et al. Short-term intensive treatment of donors with hepatic steatosis in living-donor liver transplantation. Transplantation 2005; 80: 608.
36. Hwang S, Lee SG, Jang SJ, et al. The effect of donor weight reduction on hepatic steatosis for living donor liver transplantation. Liver Transpl 2004; 10: 721.